{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:10:22Z","timestamp":1785885022634,"version":"3.56.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T00:00:00Z","timestamp":1290988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aims:\u2002<\/jats:bold>To determine what clinical factors relating to efficacy besides complications of orthopedic surgery for patients treated with anti\u2010tumor necrosis factor (TNF)\u2010\u03b1 therapy (infliximab), we analyzed the clinical data of 52 cases of orthopedic surgery, such as total hip arthroplasy (THA), total knee arthroplasty (TKA), total shoulder arthroplasy (TSA), total elbow arthroplasty (TEA), arthroscopic synovectomy, foot arthroplasty, spine surgery, hand surgery and fracture.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>We analyzed clinical factors including age, disease duration, preoperative C\u2010reactive protein (CRP), disease activity score (DAS)\u201028, matrix metalloproteinase (MMP)\u20103, and rheumatoid arthritis particle\u2010agglutination (RAPA) in 52 cases of rheumatoid arthritis (RA) undergoing orthopedic surgery. For complications of orthopedic surgery, signs of postoperative infection were recorded, including rubor, discharge, systemic infection and frequencies of wound dehiscence, as well as the incidence of any surgical complication requiring a secondary revision procedure were measured.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Signs of infection or surgical complications occurred in two of 52 patients (3.8%). There is significant correlation between RAPA and improvement of CRP 3\u2003months after surgery; however, there is no correlation between infection and clinical factors including age, disease duration, preoperative CRP, MMP\u20103, RAPA and the period until surgery after infliximab infusion.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>Infliximab did not increase the risk of either infections or surgical complications occurring in patients with RA within 1\u2003year of orthopedic surgery. Improvement of CRP after surgery is likely to be due to infliximab for high RAPA in RA patients.<\/jats:p>","DOI":"10.1111\/j.1756-185x.2010.01579.x","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T08:44:06Z","timestamp":1291020246000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab"],"prefix":"10.1111","volume":"14","author":[{"given":"Koichiro","family":"HAYATA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"KANBE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"CHIBA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"INOUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"HOBO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21405"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21841"},{"key":"e_1_2_7_7_2","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti\u2010tumor necrosis factor: a large retrospective study","volume":"34","author":"Den Broeder AA","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles","volume":"117","author":"Waaler E","year":"1940","journal-title":"Acta Pathol Microbiol Scand"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0002-9343(56)90103-6","article-title":"The latex fixation test","volume":"21","author":"Singer JM","year":"1956","journal-title":"Am J Med"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90190-9"},{"key":"e_1_2_7_11_2","first-page":"216","article-title":"Occurrence and predictors of joint surgery in the Utrecht rheumatoid arthritis cohort [abstract]","volume":"64","author":"Verstappen SMM","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10998"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.3.214"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02032339"},{"key":"e_1_2_7_16_2","first-page":"1449","article-title":"Incidence and risk factors for prosthetic joint infections in patients with rheumatoid arthritis following total knee and total hip replacement [abstract]","volume":"52","author":"Bongartz T","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432202"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901283400401"},{"key":"e_1_2_7_20_2","first-page":"2563","article-title":"Adalimumab, a fully human anti tumor necrosis factor\u2010alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)","volume":"30","author":"Furst DE","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_7_21_2","first-page":"S71","article-title":"Serious infections in rheumatoid arthritis: relationship to immunosuppressive use","volume":"42","author":"Singh G","year":"1999","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_22_2","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen\u2010Witrand A","year":"2007","journal-title":"Clin Exp Rheumatol"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2010.01579.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2010.01579.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T15:36:33Z","timestamp":1711985793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2010.01579.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1756-185X.2010.01579.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2010.01579.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,29]]},"assertion":[{"value":"2010-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}